Hound Partners’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-750,000
Closed -$7.36M – 63
2021
Q4
$7.36M Hold
750,000
– – 0.41% 29
2021
Q3
$7.37M Buy
+750,000
New +$7.41M 0.39% 28

Other funds holding DALS

Hound Partners's DALS Position: Q1 2022 in Review

Hound Partners sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q1 2022, closing a stake of 750,000 shares — an estimated $7.36M sold.

Hound Partners first reported a position in DALS in Q3 2021 and held it in 2 quarters. The position peaked at $7.37M in Q3 2021. 44 funds tracked by Wall St. Rank hold DALS as of Q1 2022.

  • Hound Partners reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q1 2022 after selling out during the quarter.
  • Hound Partners sold 750,000 DA32 Life Science Tech Acquisition Corp shares in Q1 2022, an estimated $7.36M.
  • Hound Partners first reported a position in DA32 Life Science Tech Acquisition Corp in Q3 2021 and held it in 2 quarters.
  • Hound Partners's DA32 Life Science Tech Acquisition Corp position peaked at $7.37M in Q3 2021.
  • 44 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q1 2022.

Based on Hound Partners's 13F filing for Q1 2022, filed 13 May 2022.